Original paper
P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas v2 After Acquired Resistance to Afatinib
Abstract
Cell free DNA (cfDNA) genotyping in plasma by cobas EGFR Mutation Test v2 (cobas test) is the first liquid biopsy approved as companion diagnostic systemtest to identify patients with EGFR T790M (T790M) mutation after first-generation EGFR-TKIs (G: gefitinib and erlotinib: E) and second-generation EGFR-TKIs (afatinib) failure. However, it remains unclear whether cobas testin plasma is sufficient method for detecting T790M mutation after afatinib...
Paper Details
Title
P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas v2 After Acquired Resistance to Afatinib
Published Date
Dec 1, 2018
Journal
Volume
13
Issue
12
Pages
S1073 - S1074
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History